Investigation of the pathogenesis of autoimmune diseases by IPS cells

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The pluripotent stem cells have a self-renewal ability and can be differentiated into theoretically all of cell types. The induced pluripotent stem (iPS) cells overcame the ethical problems of the human embryonic stem (ES) cell, and enable pathologic analysis of intractable diseases and drug discovery. The in vitro disease model using disease-specific iPS cells enables repeated analyses of human cells without influence of environment factors. Even though autoimmune diseases are polygenic diseases, autoimmune disease-specific iPS cells are thought to be a promising tool for analyzing the pathogenesis of the diseases and drug discovery in future.

Cite

CITATION STYLE

APA

Natsumoto, B., Shoda, H., Fujio, K., Otsu, M., & Yamamoto, K. (2017). Investigation of the pathogenesis of autoimmune diseases by IPS cells. Japanese Journal of Clinical Immunology, 40(1), 48–53. https://doi.org/10.2177/jsci.40.48

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free